NXP Semiconductors (NXPI) continues to be a talking point in the bio-tech market. Many major entities are buying, selling, and adjusting their position in NXPI stock.
111 Capital,
ASR Vermogensbeheer N.V,
Mirae Asset Global Investments Co. Ltd, and
GC Wealth Management RIA LLC were some who acquired more shares, while
HB Wealth Management LLC,
J. Safra Sarasin Holding AG, and
Trivium Point Advisory LLC detached some of their holdings. NXPI's stock saw varied performances, with it sinking even amidst market gains and also rising higher than the market at times.
Goldman Sachs has initiated coverage on NXPI's stock with a Buy rating, bolstering the stock's prospects. Assessments on share valuation, earnings and outlooks are being analyzed amid continued interest in NXPI, and the company even updated its buyback program by repurchasing 1.1 million shares. However, concerns linger, particularly after
Jim Cramer commented on how NXPI struggled due to automotive issues, and other entities sold a significant percentage of their holdings.
Nxp Semiconductors Stocks NXPI News Analytics from Wed, 05 Mar 2025 08:00:00 GMT to Sat, 04 Oct 2025 18:30:07 GMT -
Rating 0
- Innovation 0
- Information 8
- Rumor -5
